Search Results

Press Releases

Biocodex Strengthens Supply Chain Resilience with Kinaxis

December 16, 2024

·

2 min read

Press Releases

Biocodex Microbiota Foundation Announces Open Call for Project for $50,000 2025 USA Microbiome Research Grant

February 3, 2025

·

3 min read

Pharm Country

Biocodex Microbiota Foundation Announces Open Call For 2024 USA Microbiome Research Grant

The Biocodex Microbiota Foundation is announcing the 2024 open call for applications for its annual USA research grant.

June 25, 2024

·

3 min read

Press Releases

Biocodex to present new data at the American Epilepsy Society (AES) 2024 Annual Meeting

December 3, 2024

·

7 min read

Press Releases

New Development in Rare Pediatric Epilepsy: Biocodex Announces the Development of DIACOMIT® (stiripentol) Oral Suspension, a New Formulation to Aid in the Treatment of Dravet Syndrome in Young Children

November 14, 2024

·

6 min read

Press Releases

Final Call for Biocodex Microbiota Foundation $50,000 2024 USA Microbiome Research Grant

August 7, 2024

·

3 min read

Pharm Country

PANTHERx® Rare Announces Partnership with Biocodex for the Distribution of DIACOMIT® (stiripentol) for the Treatment of Seizures Associated with Dravet Syndrome in Patients 2 Years of Age and Older Taking Clobazam

PANTHERx Rare announces that it has been selected by Biocodex as their new exclusive U.S. pharmacy distribution partner for DIACOMIT® (stiripentol).

June 27, 2022

·

3 min read

The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases

The Biocodex Microbiota Foundation is looking for academics and scientists in Canada to apply for a €25,000 research grant aimed at helping advance the study of the gut microbiome

August 17, 2020

·

2 min read

Press Releases

Dravet Syndrome Market Size to Reach USD 854.0 Million by 2035, Impelled by Advancements in Gene Therapy and Personalized Medicine

January 30, 2025

·

12 min read

Genetown

2019 International Biocodex Microbiota Foundation grant: Prof. Emily Balskus rewarded for her research on inhibiting the gut microbiota’s degradation of Parkinson’s disease medication

The International Biocodex Microbiota Foundation has awarded its 2019 grant to Emily Balskus, Professor of Chemistry and Chemical Biology at Harvard University. “I am extremely honored to be chosen to receive this grant and am very grateful to the Biocodex Microbiota Foundation for supporting my research”, Prof. Balskus immediately reacted.

September 10, 2019

·

6 min read